Biopharmaceutics Classification System: Evaluation on International Guidelines and Countries
نویسندگان
چکیده
منابع مشابه
BIOPHARMACEUTICS DRUG DISPOSITION CLASSIFICATION SYSTEM: AN EXTENSION OF BIOPHARMACEUTICS CLASSIFICATION SYSTEM Kataria
The Biopharmaceutics Classification System (BCS) was developed for prediction of in vivo pharmacokinetic performance of drug products from measurements of permeability and solubility. If the permeability criteria changed with metabolism criteria than it may be useful in predicting overall drug disposition, including routes of drug elimination and the effects of efflux and absorptive transporter...
متن کاملInternational Journal of Biopharmaceutics
The present study investigates the effect of Withania somnifera (WS), a well-known adaptogenic agent in Indian system of Medicine, on acute cerebral reperfusion and long-term cerebral hypoperfusion in rats. Acute ischemiareperfusion (30 min occlusion of bilateral common carotid arteries followed by 45 min. reperfusion) and Long-term cerebral hypoperfusion (for 15 days) in C.F. strain rats were ...
متن کاملBiopharmaceutics Classification System: A Regulatory Approach
The Biopharmaceutics Classification System (BCS) is the result of continuous efforts in mathematical analysis for the elucidation of the kinetics and dynamics of the drug process in the gastrointestinal tract (GIT) for NDA (New Drug Application) and ANDA (Abbreviated New Drug Application) filings and biowaivers. This step reduces timelines in the new drug development process, both directly and ...
متن کاملHealth Expenditures in Developing Countries: Determinants and Guidelines
Background: In this paper, the health expenditures function of developing countries is estimated with a panel data model. Methods: All credible determinants of health expenditures in these countries are probed and their coefficients are found out. Variables that affect health expenditures in developing countries are income, demographic features, social characteristics, and technological progr...
متن کاملBioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy.
The demonstration of bioequivalence (BE) is an essential requirement for ensuring that patients receive a product that performs as indicated by the label. The BE standard for a particular product is set by its innovator, and this standard must subsequently be matched by generic drug products. The Biopharmaceutics Classification System (BCS) sets a scientific basis for an improved BE standard fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Literature Pharmacy Sciences
سال: 2018
ISSN: 2630-5569
DOI: 10.5336/pharmsci.2018-61223